We, therefore, tested the ability of NPM1 to prevent the aggregation of amyloid-β1–42 (Aβ42), which has been found in the nuclei of neurons from Alzheimer's disease patients and is considered a model for amyloid formation (20, 21). Here, NPM1 is linked to early-onset autosomal dominant Alzheimer disease.